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The most frequent complication of the venous redirec•
tion (Mustard or Senning) operation for transposition 
of the great arteries is cardiac arrhythmia. Drug treat•
ment of tachyarrhythmia often worsens bradyarrhyth•
mia. Pacemakers can now treat both arrhythmias. The 
technique for implantation of pacemakers after redirec•
tion for transposition has changed over time from tho•
racotomy to subxiphoid to transvenous. Atrial pacing is 
almost always the mode of choice since the electrophys•
iologic abnormality is sinus node dysfunction with intact 
atrioventricular conduction. 
Twenty-nine patients aged 3 to 19 years (mean 9.6) 
had implantation of a pacemaker a mean of 5.5 years 
Venous redirection (the Mustard or Senning operation) re•
mains the standard definitive treatment for patients with 
d-transposition of the great arteries (1,2). It has the lowest 
hospital mortality rate, and hemodynamic correction is usu•
ally excellent (3-5). Bradycardia due to sinus node dys•
function is the most frequent problem encountered in 
patients after the Mustard operation. Supraventricular 
tachyarrhythmias, including supraventricular tachycardia and 
atrial flutter, are seen less frequently. This combination of 
bradyarrhythmias and tachyarrhythmias complicates the 
treatment of each. Virtually all drugs that are effective in 
treating supraventricular tachycardia or atrial flutter have 
negative chronotrophic effects on the sinus node. Digoxin 
seems to be fairly well tolerated in most patients after the 
Mustard operation but quinidine and propranolol have fre•
quently resulted in severe bradycardia (6). We have there•
fore recommended against the use of any antiarrhythmic 
drugs, except digitalis, without implantation of a pace-
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(range 1 to 14) after undergoing the Mustard operation 
for transposition of the great arteries. Symptoms refer•
able to bradycardia were eliminated in each case. Four 
patients who received an anti tachycardia pacemaker no 
longer have symptomatic tachycardia. Four patients have 
required reoperation, three because of lead problems 
and one because of traumatic erosion of the pacemaker. 
Pacemakers provide excellent relief of symptoms after 
the Mustard or Senning operation. Transvenous atrial 
automatic anti tachycardia pacemakers offer the best 
combination of ease of implantation and symptomatic 
relief. 
(J Am Coll Cardiol 1986;7:138-41) 
maker. This report discusses our results in 29 patients who 
underwent permanent pacemaker implantation after under•
going the Mustard operation. 
Methods 
Study patients. Records of the pacemaker clinic at the 
Medical University of South Carolina Hospital and the Texas 
Children's Hospital were reviewed to determine which pa•
tients who received a pacemaker had previously undergone 
the Mustard operation for transposition of the great arteries. 
The patients' clinical records were then evaluated from the 
files of the Divisions of Pediatric Cardiology. The patient's 
age at implantation of the pacemaker, technique of implan•
tation of the pacemaker, mode of pacing, duration of pacing, 
number of reoperations and effect of the pacemaker on the 
patient's tachycardia spells were recorded. Symptomatic im•
provement was also evaluated. 
Implantation techniques. The technique of implanta•
tion underwent a series of changes over the years. In the 
early 1970s, thoracotomy was performed for implantation 
of a pacemaker in a child. The thoracotomy was performed 
on the left side of the chest and either the base of the left 
atrial appendage or the left ventricle could be isolated for 
implantation of a permanent pacing lead. A screw-in lead 
was used for the ventricle and a plaque type sew-on lead 
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for the atrium. The left side was considered superior for 
atrial pacing in patients who had undergone the Mustard 
operation because there were fewer adhesions and less scar•
ring of the atrial epicardium. 
In the mid 1970s the techniques of subcostal and subxi•
phoid implantation of ventricular leads were developed. These 
had the advantage of not requiring a full thoracotomy and 
therefore shortened the postoperative recovery period con•
siderably. The pulse generator was implanted beneath the 
rectus muscle so that the distance between the pulse gen•
erator and the tip of the lead was much smaller. Initially, 
atrial leads were not thought to be implantable by this tech•
nique. Therefore, most children had ventricular demand 
pacing even though it was believed to be more physiologic 
to use atrial pacing in patients with the sick sinus syndrome. 
Later, a technique of implantation of a stab-on lead on the 
atrium by the subxiphoid approach was developed for pa•
tients who had not had previous open heart surgery and 
subsequently for those who had. 
Transvenous implantation (Fig. 1 to 3). In 1981, we 
began performing transvenous pacemaker implantation in 
children in the cardiac catheterization laboratory. This tech•
nique was used in patients who underwent the Mustard 
operation. It involved entry of the subclavian vein by an 
introducer technique, positioning of a screw-in lead in the 
roof of the new right atrium (the anatomic left atrium) (Fig. I). 
Transvenous implantation was attempted in 18 patients in 
this series. In 2 of these 18 patients, initial catheterization 
studies demonstrated complete or nearly complete obstruc•
tion of the superior vena cava and right atrial junction. and 
Figure 1. Posteroanterior chest radiograph showing a single chamber 
pacemaker implanted as an atrial demand pacemaker using a screw•
in lead in the roof of the anatomic left atrium (functional right 
atrium). Extra slack has been left to allow growth. The lead was 
positioned through the right subclavian vein. The patient weighed 
18 kg. 
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Figure 2. Posteroanterior chest radiograph showing a dual cham•
ber pacemaker implanted in a postoperative Mustard patient who 
had abnormal atrioventricular conduction. A J-shaped screw-in 
lead was used for the atrium and a straight screw-in for the left 
ventricle. An old epicardial ventricular lead is also shown over 
the lower ventricle. The stump of an old epicardial atrial lead is 
just beneath the pacemaker. 
no attempt was made to implant a transvenous lead. In a 
third patient, although there was total obstruction of blood 
flow between the superior vena cava and the new right 
atrium, a large portion of the right atrium, including most 
of the right atrial appendage, was left connected to the 
superior vena cava, and a bipolar J-shaped lead was posi•
tioned in the stump of the right atrial appendage and estab•
lished excellent thresholds and sensing capabilities. In a 
Figure 3. Posteroanterior chest radiograph showing the use of two 
screw-in leads with an atrial demand antitachycardia pacemaker. 
Each lead was positioned in the roof of the anatomic left atrium . 
.. <:.:." II \ .. ,.t,." ~ "'l",_~~. 
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fourth patient, although a large portion of the atrium was 
accessible from the superior vena cava, adequate thresholds 
could not be obtained. In 14 patients, it was possible to pass 
a transvenous screw-in electrode through the superior vena 
cava-new right atrial junction and position it in the roof of 
the anatomic left atrium. In three patients, two screw-in 
leads were passed through the superior vena cava-new right 
atrial junction (Fig. 2 and 3). In two of these three, two 
leads were positioned in the atrium and used for a bipolar 
antitachycardia pacemaker (AAIMB). In the third patiert, 
an automatic iltrioventricular (A V) sequential pacemaker 
(DDD) was used. 
Several different brands of standard single chamber pace•
makers were used. Each had rate and output programma•
bility in common. The same models of pulse generators 
were used for atrial and ventricular pacing. Standard AV 
sequential and automatic units were used. An automatic 
antitachycardia pacemaker was used in four patients (Cy•
bertach in two and Intertach in two). 
Follow-up. Follow-up study consisted of an outpatient 
evaluation lit 6 weeks and yearly thereafter. Transtelephonic 
follow-up study was performed every month for I year and 
every 3 months thereafter. Electrocardiograms and chest X•
ray films were obtained at each visit. Twenty-four hour 
electrocardiographic monitoring and exercise testing were 
performed if any symptoms were reported. Antiarrhythmic 
medications were used as clinically indicated. 
Results 
Twenty-nine patients aged 3 to 19 years had implantation. 
of a permanent cardiac pacemaker at an average age of 9.6 
years (SD = 4.4). Three patients had their pacemaker im•
planted during their hospitalization for the Mustard opera•
tion. The difference in time between the Mustard operation 
and the pacemaker implantation for the remaining 26 pa•
tients ranged from I to 14 years (mean 5.5). 
Indications. In 16 patients the indication for insert jon 
of the pacemaker was the occurrence of symptoms: syncope, 
near syncope, dizziness or extreme exercise intolerance. Of 
the remaining 13 patients, 10 required drugs other than 
digitalis to control supraventricular arrhythmias and 3 had 
an extremely low heart rate although they were asympto•
matic. In two of the three, the low heart rate (30 beats/min) 
occurred only at night; in the third, heart rates of less than 
40 beats/min were recorded during awake activity. 
Follow-up. The follow-up period ranged from I month 
to 9 years (mean 3 years). During follow-up, two patients 
died. Each had had a large ventricular septal defect closed 
in addition to undergoing the Must&rd operation for trans•
position of the great arteries. Each patient had severe myo•
cardial dysfunction and at recent follow-up before death was 
found to have a normally functioning pacemaker. One of 
these two patients had had a syncopal spell in the exercise 
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laboratory due to hypotension with normal pacing by an A V 
sequential pacemaker. 
Relief of symptoms. Symptoms referable to bradycardia 
were eliminated in each symptomatic patient, 16 of 16. That 
is, none of these patients had syncope or near syncope and 
in each the exercise tolerance improved. In 10 of the 12 
patients with tachycardia the arrhythmia is no longer as•
sociated with symptoms. Four of these 10 patients were 
treated with an automatic atrial overdrive pacemaker (two 
with Cybertach and two with Intertach) (2). In three patients, 
the pacemaker has been shown to successfully overdrive 
episodes of atrial flutter. Two of these three experienced a 
brief palpitation with the flutter, whereas the third did not 
know when the flutter episodes were being overdriven. One 
patient had not had tachycardia. Of the remaining eight 
patients, six had an atrial pacemaker and two had a ven•
tricular pacemaker implanted. Two patients continued to 
have tachycardia despite increased drug use, but it was made 
easier by the pacemaker. Both had an atrial demand 
pacemaker. 
Reoperations. Twenty-five of 29 patients have not re•
quired reoperation. Two patients have required one reoper•
ation and two required two reoperations. In the latter group, 
the first patient to receive a pacemaker after the Mustard 
operation had implantation of an epicardial atrial demand 
pacemaker. After 31/2 years, the atrial lead had slid, prob•
ably because of patient growth. so that it also paced the 
ventricle. At reoperation, the tip of the lead could not be 
found because of dense fibrous adhesions so a ventricular 
lead was placed. After 31/2 years, myocardial function had 
deteriorated and the heart size had increased; thus, a trans•
venous automatic dual chamber (DDD) pacemaker was in•
serted and the ventricular pacemaker was removed. The 
other patient who required two reoperations had pacing of 
the left phrenic nerve beginning 3 weeks after trans venous 
implantation. Pulse width and ampJjtude programming was 
unsuccessful in preventing this pacing so repositioning of 
the lead away from the left heart border was carried out. 
Six months later, the pacemaker eroded as a result of severe 
physical trauma and an epicardial ventricular pacemaker was 
implanted. One patient who had implantation of a ventric•
ular epicardial pacemaker at the time of the original Mustard 
operation had a fractured lead 2 years after implantation; 
after careful ambulatory monitoring and electrophysiologic 
testing, it was decided that he no longer needed the pace•
maker and it was removed. In the remaining patient the lead 
broke during a bicycle accident 2 years after implantation 
of an epicardial ventricular demand (VVI) pacemaker. The 
lead was replaced without incident. 
Discussion 
The Mustard operation continues to be a useful physio•
logic correction for transposition of the great arteries (1-6). 
Bradyarrhythmias and tachyarrhythmias are the most fre-
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quent complications in the postoperative period. Use of an 
implanted cardiac pacemaker considerably eases the treat•
ment of patients with both bradyarrythmias and tachyar•
rhythmias. The usefulness of pacemakers has been limited 
in the past because of their large size in relation to that of 
the patient and the technical difficulty of implantation. Re•
cent developments, including the use of microchips for cir•
cuitry and improvements in battery design, have reduced 
the single chamber cardiac pacemakers to a very acceptable 
size (7). Even a dual chamber pacemaker can now be con•
sidered for children of almost any age. 
Transvenous implant technique. The advent of the 
transvenous technique has greatly decreased the morbidity 
of the implant procedure. Screw-in endocardial leads and 
the subclavian introducer technique have made transvenous 
implants possible in pediatric postoperative patients (8). In 
this study we found lead-related problems to be no more 
frequent in transvenous than in epicardial lead implants. 
The radiographic left heart border must be strictly avoided 
in transvenous implants to prevent phrenic nerve pacing. It 
is also imperative to determine that the superior vena cava•
new right atrial junction is sufficiently wide to permit the 
pacemaker lead to pass. The long-term effect of a pacing 
lead on stenosis of this area remains to be determined but 
must be followed up carefully. 
Antitachycardia pacemakers. Our results in four pa•
tients suggest that the greatest degree of tachycardia control 
will be achieved if an automatic anti tachycardia pacemaker 
is used. In patients with known or potential 1: 1 A V con•
duction of atrial flutter, consideration should be given to 
the use of digitalis to prevent death or severe symptoms 
from rapid ventricular response. A pacemaker, even an anti•
tachycardia pacemaker, will not prevent all sudden deaths 
in post-Mustard patients. Attention must be paid to the pos•
sibility that supraventricular or ventricular tachyarrhythmias 
may be present, particularly in patients who have had ad•
ditional surgery. Not only are these patients more prone to 
ventricular arrhythmias but they may be more prone to de•
veloping A V block. We have used atrial pacing in such 
patients if they had no evidence of A V block and if they 
maintained 1 : 1 A V conduction at atrial pacing rates of 120 
beats/min or greater. None of our patients have developed 
A V block. With the present reliability and size of fully 
automatic (DDD) pacemakers, our threshold for their use 
is becoming increasingly low. 
Patients who have undergone the Senning operation also 
suffer from brady arrhythmias and tachyarrhythmias. Al•
though we have no experience with these patients, we be-
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lieve that they should be treated similarly to post-Mustard 
patients. 
Indications. Our current indications for a pacemaker 
implant in a post-Mustard patient are: 1) syncope or near 
syncope, documented to be due to bradycardia; 2) the need 
to use antiarrhythmic drugs other than digitalis; 3) brady•
cardia of less than 40 beats/min while awake; and 4) brady•
cardia of less than 30 beats/min while asleep. 
Conclusion. The results of this study indicate that pac•
ing can be safely and effectively carried out in patients who 
have previously had the Mustard operation and who have 
sinus bradycardia or bradycardia-tachycardia syndrome. 
Symptoms can be relieved in most patients. The evolution 
of lead implant techniques indicates that in patients weighing 
more than 10 kg, the preferrable technique is transvenous. 
Care must be taken to ensure that there is not total superior 
vena cava-right atrial junction obstruction preventing lead 
implantation before the incision is made for pacemaker im•
plantation. The transvenous implant technique provides bet•
ter thresholds and avoids the problem of the patient in whom 
an adequate threshold cannot be obtained by the epicardial 
technique. 
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